Seven of the UK's top housebuilders are facing a massive class action lawsuit, with estimated damages potentially topping £4.5bn. The claim alleges that around 700,000 new-build buyers were overcharged due to a breach of competition law, sparking a decade-long period of suppressed competition among major developers.
The affected housebuilders include FTSE 100 constituents Barratt Redrow and Persimmon, alongside FTSE 250 firms Taylor Wimpey, Berkeley, and Bellway. Bloor Homes, Vistry Group, and its Countryside Partnerships division are also named in the action. The lawsuit is being led by Mark McLaren, a former parliamentary and legal affairs manager at consumer group Which?, and is represented by competition law firms Geradin Partners and Hausfeld.
This latest development follows a stalled investigation by the Competition and Markets Authority (CMA) into whether housebuilders shared commercially sensitive information. The inquiry, which covered a period up to February 2024, was closed in October 2025 without any formal action being taken. However, the new lawsuit alleges that reduced competition among these major players led to buyers paying more for their homes over a period exceeding ten years.
The news has sent shockwaves through the stock market, with shares in the implicated housebuilders experiencing significant declines. Persimmon's share price dropped 2.3 per cent, while Barratt Redrow fell by 1.9 per cent. On the mid-cap FTSE 250, Berkeley Group was down 1.5 per cent and Taylor Wimpey saw a 0.9 per cent weakening.
While some City experts have questioned the lawsuit's chances of success, others believe the sector is vulnerable to external pressures, particularly in light of recent struggles with rising costs and planning regulations. Analysts at RBC Capital Markets estimate that potential damages could range from £2.2bn to £4.5bn if the case succeeds.
The housebuilding sector continues to face a challenging environment, with high interest rates, increased material costs, and stringent planning regulations all taking their toll. Despite this, the lawsuit's impact on the market remains to be seen, as investors wait to see how the situation unfolds.